TANIKAWA Takashi

写真a

Affiliation

Faculty of Pharmaceutical Sciences Department of Pharmaceutical Sciences

Title

Associate Professor

External Link

Degree 【 display / non-display

  • 博士(薬学) ( 2008.03   静岡県立大学 )

From School 【 display / non-display

  • University of Shizuoka   Faculty of Pharmaceutical Science   Graduated

    - 2003.03

      More details

    Country:Japan

From Graduate School 【 display / non-display

  • University of Shizuoka   Graduate School, Division of Pharmaceutical Sciences   Doctor's Course   Completed

    - 2008.03

      More details

    Country:Japan

Studying abroad experiences 【 display / non-display

  • 2008.04 - 2011.03   University of Michigan   Postdoctoral Fellow

Employment Record in Research 【 display / non-display

  • Josai University   Faculty of Pharmaceutical Sciences   Department of Pharmaceutical Sciences   Associate Professor

    2018.04

Professional Memberships 【 display / non-display

  • 日本薬学会

  • 日本生化学会

Qualification Acquired 【 display / non-display

  • Chief Person of Radiation Handling (first and second kind)

  • Pharmacist

 

Papers 【 display / non-display

  • Effects of betulinic acid and ursolic acid on IL-17-induced CCL20 release via the ERK1/2-C/EBPβ pathway in normal human epidermal keratinocytes Reviewed

    Arai A, Oyama T, Nakajima T, Usui M, Sato E, Kamiya T, Oyama M, Tanikawa T, Takeuchi T, Abe T, Hatanaka T

    Life (Basel)   15 ( 7 )   1073   2025.07

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • Evaluation of the effects of ursolic acid/γ‑cyclodextrin or cyclodextrin‑based metal‑organic framework‑1 complexes on reducing cytotoxicity and improving muscle atrophy in C2C12 cells Reviewed

    Kuwashima R, Ishizuka M, Tanikawa T, Ishida Y, Nakata D, Terao K, Inoue Y

    Int J Fun Nutr.   6 ( 1 )   2025.07

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  • Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication Reviewed

    Hayashi T, Hirano J, Murakami K, Fujii Y, Kobayashi S, Tanikawa T, Kitamura M, Someya Y

    Biol Pharm Bull.   48 ( 7 )   994 - 1000   2025.07

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • nhibitory of Perilla-derived essential oil on SARS-CoV-2 activities in vitro Invited

    Tanikawa T, Kiba Y, Ueno T, Kenmotsu H, Suzuki R, Kitamura M

    New food Indust.   67 ( 6 )   349 - 355   2025.06

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  • Fenugreek inhibits cathepsin G activity and suppresses the progression of malignant phenotypes in MCF-7 cells Reviewed

    Tanigawa K, Tanikawa T, Kitamura M, Hayashi Y, Kiriya M, Nakamura Y, Kawashima A, Fujiwara Y, Morimoto-Kamata R, Ohkura N, Yui S, Karasawa K, Nakamura R, Suzuki K

    Biochem Biophys Rep.   42   102021   2025.04

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

display all >>